Okabayashi J, Matsubayashi K, Sato T, Ozawa T
Department of Medicine and Geriatrics, Kochi Medical School.
Nihon Ronen Igakkai Zasshi. 1994 Apr;31(4):285-92. doi: 10.3143/geriatrics.31.285.
To clarify the effect of the calcium antagonist Nifedipine and the ACE inhibitor Enalapril on cardiac autonomic activity, power spectral analysis of heart rate variability (PSA) was conducted in 39 elderly patients with essential hypertension (mean age: 63: +/- 11 years) before and after treatment. Twenty patients were treated with 10-20 mg of Nifedipine (N group) and 19 with 5 mg of Enalapril (E group) for 3 months. beta-blocker (Atenolol 12.5 mg) was added to Nifedipine in 12 patients of the N group for 1 month, and the modified effect of Atenolol on cardiac autonomic activity was also evaluated. Blood pressures were significantly reduced in both N and E groups after the treatment. The low frequency component (LF) in PSA, which was considered to be a quantitative marker of cardiac sympathetic activity, increased significantly and the high frequency component (HF), which was a marker of cardiac parasympathetic activity, significantly decreased with increase of PNA levels in N group after the treatment. However, the LF decreased significantly after addition of Atenolol. On the other hand, there was little significant change in LF and PNA in E group. These results suggest that Nifedipine increased cardiac sympathetic activity and that Enalapril had little influence on the cardiac sympathetic tone, while both antihypertensive agents significantly reduced blood pressure itself.
为阐明钙拮抗剂硝苯地平和血管紧张素转换酶抑制剂依那普利对心脏自主神经活动的影响,对39例老年原发性高血压患者(平均年龄:63±11岁)治疗前后进行了心率变异性功率谱分析(PSA)。20例患者接受10 - 20mg硝苯地平治疗(N组),19例接受5mg依那普利治疗(E组),疗程3个月。N组12例患者在服用硝苯地平的基础上加用β受体阻滞剂(阿替洛尔12.5mg)1个月,并评估阿替洛尔对心脏自主神经活动的改善作用。治疗后N组和E组血压均显著降低。治疗后N组中,PSA的低频成分(LF)被认为是心脏交感神经活动的定量标志物,其随血浆去甲肾上腺素(PNA)水平升高而显著增加,而作为心脏副交感神经活动标志物的高频成分(HF)则显著降低。然而,加用阿替洛尔后LF显著降低。另一方面,E组LF和PNA几乎无显著变化。这些结果表明,硝苯地平增加了心脏交感神经活动,依那普利对心脏交感神经张力影响较小,而两种降压药本身均显著降低了血压。